Therapeutic Asset Ratings
435 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Palbociclib
Recurrent Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Regorafenib
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(60)
TAMOXIFEN
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
TRASTUZUMAB
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
TRASTUZUMAB
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
TRASTUZUMAB
Recurrent Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Recurrent Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Refractory Multiple Myeloma
OHSU Knight Cancer Institute
P2
B
(60)
VEMURAFENIB
Breast Cancer
OHSU Knight Cancer Institute
P2
B
(60)
VEMURAFENIB
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P2
B
(60)
Venetoclax
Acute Monocytic Leukemia
OHSU Knight Cancer Institute
P2
B
(60)
(+)-VINCRISTINE
Sarcoma
OHSU Knight Cancer Institute
P2
B
(60)
Vinorelbine
Atypical Chronic Myeloid Leukemia
OHSU Knight Cancer Institute
P2
B
(60)
Vinorelbine
Myelodysplastic/Myeloproliferative Neoplasm
OHSU Knight Cancer Institute
P2
B
(60)
LENVATINIB
Hematopoietic And Lymphoid System Neoplasm
OHSU Knight Cancer Institute
P3
B
(59)
Olaparib
Hematopoietic And Lymphoid System Neoplasm
OHSU Knight Cancer Institute
P3
B
(59)
Gdc-0449
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
B
(59)
Gdc-0449
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(59)
Gdc-0449
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(59)
Gdc-0449
Recurrent Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(59)
gsk1120212
Breast Carcinoma
OHSU Knight Cancer Institute
P2
B
(59)
Showing 126 to 150 of 435 assets
Previous
Page 6 of 18
Next